|
Description:
|
|
Featuring articles on teplizumab in relatives at risk for type 1 diabetes, complement blockade for neuromyelitis optica spectrum disorder, BRAF and MEK inhibition in melanoma, liraglutide in children and adolescents with diabetes, the “All of Us” research program, and recognition for discoveries in DNA repair; a review article on autoimmune hemolytic anemia; a case report of a pregnant woman with abdominal pain; and Perspective articles on reproductive (in)justice, on reevaluating U.S. mifepristone restrictions, on a plan to continue asbestos use in the United States, and on Mike’s labels. |